Drug induced akathisia
ICD-10 G25.71 is a billable code used to indicate a diagnosis of drug induced akathisia.
Drug induced akathisia is a movement disorder characterized by a subjective feeling of inner restlessness and an uncontrollable need to be in constant motion. This condition is often associated with the use of dopaminergic medications, particularly antipsychotics and certain antiemetics, which can lead to extrapyramidal symptoms. Patients may exhibit behaviors such as pacing, fidgeting, or an inability to sit still. The pathophysiology of drug induced akathisia is thought to involve alterations in dopaminergic pathways, particularly in the basal ganglia, which are crucial for the regulation of movement. Clinically, akathisia can significantly impact a patient's quality of life and may lead to non-compliance with medication regimens. Diagnosis is primarily clinical, based on patient history and symptomatology, and it is essential to differentiate akathisia from other movement disorders, such as Parkinson's disease or restless legs syndrome, which may present with similar symptoms but have different underlying causes and treatment approaches.
Detailed medication history, symptom assessment, and treatment response documentation.
Patients on antipsychotic medications presenting with restlessness or agitation.
Consideration of alternative diagnoses and the impact of medication adjustments on symptoms.
Comprehensive neurological examination and assessment of movement disorders.
Patients with Parkinson's disease experiencing exacerbation of symptoms due to medication changes.
Differentiating between drug induced akathisia and primary movement disorders.
Used when evaluating a patient with drug induced akathisia during a follow-up visit.
Document the patient's medication history, symptom severity, and treatment response.
Psychiatric evaluations may require additional documentation of mental status and functional impact.
The primary cause of drug induced akathisia is the use of dopaminergic medications, particularly antipsychotics, which can disrupt normal motor function and lead to feelings of restlessness.
